CFCThe Compounder Score
TLRY logo

TLRY — Tilray Brands, Inc.

Drug Manufacturers - Specialty & GenericHealthcare

$2.43

$-0.06 (-2.41%)

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness.

Market Cap

$359.12M

Forward P/E

17.1x

52-Week Range

N/A

TLRY Price History

No cached price history available for this ticker yet.

Revenue vs. Net Income

$915M

Revenue · FY2026

Annual. Net margin is shown under each year.

RevenueNet income (green profit, red loss)

Free Cash Flow

-$102M

FCF · FY2026

Annual. FCF margin is shown under each year.

Return on Capital Employed (ROCE)

-3.0%

ROCE · FY2026

Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.

Total Assets vs. Total Liabilities

3.3x

Assets ÷ liabilities · FY2026

Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.

Total assetsTotal liabilities

CapEx as % of Revenue

3.6%

CapEx · FY2026

Annual. Green at or under the 5% maximum target, red above it.

Shares Outstanding

+25.6%

Dilution · FY2026

Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).